Your browser doesn't support javascript.
loading
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition.
Haagensen, E J; Kyle, S; Beale, G S; Maxwell, R J; Newell, D R.
Affiliation
  • Haagensen EJ; Drug Discovery and Imaging, Newcastle Cancer Centre, Northern Institute for Cancer Research, Medical School, Newcastle University, Newcastle-upon-Tyne, UK.
Br J Cancer ; 106(8): 1386-94, 2012 Apr 10.
Article in En | MEDLINE | ID: mdl-22415236
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / TOR Serine-Threonine Kinases Limits: Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / TOR Serine-Threonine Kinases Limits: Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido